Cargill joins USAID project to combat threat of infectious diseases, antimicrobial resistance to human and animal health

The five-year animal agriculture program will increase the capacity of farmers, governments and other stakeholders to prevent and quickly respond to growing human health security risks.

Cargill joins USAID project to combat threat of infectious diseases, antimicrobial resistance to human and animal health
April 15, 2021

The United States Agency for International Development (USAID) tapped a consortium led by Cargill and including Ausvet, Heifer International and the International Poultry Council (IPC) to improve livestock management and combat the threat of zoonotic diseases to both human and animal health. The five-year, $33 million Transformational Strategies for Farm Output Risk Mitigation (TRANSFORM) consortium will harness innovation to sustainably improve animal health, strengthen animal agriculture production systems in Asia and Africa and enhance global health security.

As a farm-based initiative, TRANSFORM will prioritize efforts to significantly decrease the risks of antimicrobial resistance (AMR) and zoonoses, diseases spread from animals to humans such as foodborne pathogens, anthrax and Avian and swine influenza. Scientists estimate that more than three out of five known infectious diseases in people can be spread from animals, and 75% of new or emerging infectious diseases in people come from animals. Smallholder farmers around the world are particularly vulnerable to transboundary animal diseases, with livestock representing their main source of food and income, and access to veterinary services often limited.

Together, Cargill, Ausvet, Heifer International and the IPC will increase the capacity of government, agribusinesses, and farmers to prevent and, if needed, identify and quickly respond to these threats to human health. “We know that agriculture can help solve some of the world’s most pressing challenges,” said Chuck Warta, head of Cargill Health Technologies. “We’re honored to have been selected to lead this important work and are confident that Cargill’s global reach and research capabilities, combined with our partners’ unique expertise and influence in animal agriculture, can minimize these massive threats to our global food system and human health.”

TRANSFORM will work in several key geographies, on large and small farms, with a variety of species. Beginning in 2022, Cargill will conduct nutrition and immune health trials on dairy, poultry, shrimp and swine operations in four countries throughout Asia and Africa to better understand and quantify the role holistic animal nutrition can play in reducing the threats of zoonotic diseases to human health.

The key to the consortium’s success will be developing and implementing innovative and market-driven solutions that increase access to safe, affordable, high-quality animal-sourced nutrition while improving global human health security.